Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 2651 to 2700 of 3761 results for treatment

  1. Oral health in care homes (QS151)

    This quality standard covers oral health, including dental health and daily mouth care, for adults in care homes (with and without nursing provision). It describes high-quality care in priority areas for improvement.

  2. Technology appraisal committee D members

    Find out more about NICE technology appraisals advisory committee D members

  3. Technology appraisal committee D members

    Find out more about NICE technology appraisals advisory committee D members

  4. Leukomed Sorbact for preventing surgical site infection (HTG567)

    Evidence-based recommendations on Leukomed Sorbact for preventing surgical site infection after caesarean section or vascular surgery.

  5. Radiofrequency-assisted liver resection (HTG136)

    Evidence-based recommendations on radiofrequency-assisted liver resection. This involves using high-frequency radio waves to remove the cancerous part of the liver with minimal blood loss.

  6. Further research into the comparative efficacy and safety of different surgical and ablative treatments would be useful.

    the comparative efficacy and safety of different surgical and ablative treatments would be useful. Any explanatory notes(if applicable)...

  7. Vagus nerve stimulation for treatment-resistant depression (IPG330)

    This guidance has been updated and replaced by NICE HealthTech guidance 551.

  8. LiMAx system for assessing the functional capacity of the liver (MIB168)

    NICE has developed a medtech innovation briefing (MIB) on LiMAx system for assessing the functional capacity of the liver .

  9. Home-testing devices for diagnosing obstructive sleep apnoea hypopnoea syndrome (HTG735)

    Evidence-based recommendations on home-testing devices for diagnosing obstructive sleep apnoea hypopnoea syndrome.

  10. Endovascular stent–grafts for the treatment of abdominal aortic aneurysms (TA167)

    This guidance has been updated and replaced by NICE guideline NG156.

  11. Advocacy services for adults with health and social care needs (NG227)

    This guideline covers advocacy for people using health and social care services in all adult settings (including young people under 18 using adult services). It describes how to commission and deliver effective advocacy, as well as identifying who should be offered advocacy (including who is legally entitled to it). It also covers monitoring and improving advocacy services, and training and skills for advocates and practitioners.

  12. ImmunoCAP ISAC 112 for multiplex allergen testing (HTG413)

    Evidence-based recommendations on multiplex allergen testing, using ImmunoCAP ISAC 112 in people with allergy that is difficult to diagnose.

  13. Reducing sexually transmitted infections (NG221)

    This guideline covers interventions to prevent sexually transmitted infections (STIs) in people aged 16 and over. It aims to reduce the transmission of all STIs, including HIV, and includes ways to help increase the uptake of STI testing and vaccines for human papillomavirus (HPV) and hepatitis A and B.

  14. Boston Keratoprosthesis Type I for corneal blindness (MIB91)

    NICE has developed a medtech innovation briefing (MIB) on Boston Keratoprosthesis Type I for corneal blindness .

  15. DOAC Dipstick for detecting direct oral anticoagulants (MIB248)

    NICE has developed a medtech innovation briefing (MIB) on DOAC Dipstick for detecting direct oral anticoagulants .

  16. What is the relative effectiveness of sertraline compared with cognitive behavioural therapy (CBT) in people with generalised anxiety disorder (GAD) that has not responded to guided self-help and psychoeducation in a stepped-care model?

    sertraline and cognitive behavioural therapy (CBT) are efficacious in the treatment of generalised anxiety disorder (GAD) but their...

  17. Botulinum toxin type A:- What is the clinical and cost effectiveness of botulinum toxin type A when used routinely or according to clinical need in children and young people who are at Gross Motor Function Classification System (GMFCS) level I, II or III?

    that clear treatment goals that will positively influence the child or young person's life should be identified before offering this...

  18. Percutaneous insertion of a cerebral protection device to prevent cerebral embolism during TAVI (HTG515)

    Evidence-based recommendations on percutaneous insertion of a cerebral protection device to prevent cerebral embolism during TAVI in adults. This involves placing a device inside an artery near the heart.

  19. Rimonabant for the treatment of overweight and obese adults (TA144)

    This appraisal has been withdrawn. This is because the marketing authorisation for rimonabant was withdrawn on 16 January 2009.

  20. Atrial fibrillation and heart valve disease: self-monitoring coagulation status using point-of-care coagulometers (the CoaguChek XS system) (HTG353)

    Evidence-based recommendations on the CoaguChek XS system for self-monitoring coagulation status in adults and children. The recommendations originally included the InRatio2 PT/INR, but this was withdrawn from the market in October 2016 and is not currently available.

  21. OpenAthens eligibility

    Check to see if you're entitled to access a range of content purchased by the NHS. If you are eligible, you can register for an OpenAthens account using our online form.

  22. Buy books, journals and databases

    Our framework agreement allows UK NHS, health and social care organisations to buy knowledge resources that support practice, learning and development.

  23. Liver disease:- Should all children with meconium ileus receive ursodeoxycholic acid from diagnosis?

    meconium ileus are at an increased risk of liver disease, and starting treatment with ursodeoxycholic acid from diagnosis may reduce...

  24. Endovenous laser treatment of the long saphenous vein (IPG52)

    We have moved interventional procedures guidance 52 to become HealthTech guidance 26. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

  25. Percutaneous cementoplasty for palliative treatment of bony malignancies (IPG179)

    We have moved interventional procedures guidance 179 to become HealthTech guidance 117. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

  26. Promoting health and preventing premature mortality in black, Asian and other minority ethnic groups (QS167)

    This quality standard covers promoting health and preventing premature mortality among black, Asian and other minority ethnic groups. It is relevant to all age groups and all settings.

  27. Specific versus generic CBT for children and young people with social anxiety disorder:- What is the clinical and cost effectiveness of specific CBT for children and young people with social anxiety disorder compared with generic anxiety-focused CBT?

    with these generic treatments than those with other anxiety disorders. There have, however, been no direct comparisons of...

  28. What is the clinical and cost effectiveness of cannabis-based medicinal products other than THC: CBD spray for children, young people and adults with spasticity? In particular, what is the impact of spasticity on improvements in quality of life?

    patient-reported spasticity and no difference in adverse events in the treatment or placebo groups, although much of the evidence was...

  29. Pain management: small duct disease:- What is the most clinically effective and cost-effective intervention for managing small duct disease (in the absence of pancreatic duct obstruction, inflammatory mass or pseudocyst) in people with chronic pancreatitis presenting with pain?

    other and with no treatment: surgery (partialresection, total resection with or without islet transplant, or drainage), endoscopic...

  30. Pharmacological therapy for advanced liver fibrosis in children and young people:- What is the clinical and cost effectiveness of pharmacological therapy in children and young people with advanced liver fibrosis?

    at risk of developing advanced stages of liver disease. Pharmacological treatment (for example, pioglitazone or vitamin E) could prevent...

  31. Is acupuncture effective in reducing alcohol consumption compared with standard care?

    notes(if applicable) Why this is important:- Non-pharmacological treatments are an important therapeutic option for people with...

  32. Pulmonary hypertension:- What are the most clinical and cost-effective treatments for pulmonary hypertension in people with COPD?

    Pulmonary hypertension:- What are the most clinical and cost-effective treatments for pulmonary hypertension in people with COPD? Any...

  33. What methods are most effective for assessing and diagnosing the presence and severity of alcohol misuse in children and young people?

    the NHS to both assess the severity of the alcohol misuse and to guide treatment decisions. No similar well-developed measures exist for...

  34. Mucoactive agents:- What is the most clinically and cost-effective dose of rhDNase (dornase alfa; recombinant human deoxyribonuclease) for people with cystic fibrosis?

    important- People with cystic fibrosis often have complex treatment schedules, which can include multiple nebulised...

  35. For which people with impetigo are antiseptics as effective as antibiotics?

    However, impetigo is highly infectious, and the committee agreed that treatment is important to limit the spread of infection and the...

  36. Microwave ablation for the treatment of metastases in the liver (IPG220)

    This guidance has been updated and replaced by NICE interventional procedure guidance 406.

  37. Boceprevir for the treatment of genotype 1 chronic hepatitis C (TA253)

    Boceprevir is no longer available in the UK so this guidance has been withdrawn.

  38. MiraQ for assessing graft flow during coronary artery bypass graft surgery (HTG275)

    Evidence-based recommendations on MiraQ for assessing graft flow during coronary artery bypass graft surgery.

  39. Wireless capsule endoscopy for investigation of the small bowel (HTG62)

    Evidence-based recommendations on wireless capsule endoscopy for investigation of the small bowel. This involves the person swallowing a small capsule containing a tiny camera that takes pictures as it passes through the body.

  40. Prevalence of anaphylactic reactions and related outcomes:- What is the annual incidence of anaphylaxis and its related outcomes within the UK?

    misclassification of milder reactions. Data should also be collected on any emergency treatment that was delivered (by a clinician, use...

  41. What is the annual incidence of anaphylaxis and its related outcomes within the UK?

    misclassification of milder reactions. Data should also be collected on any emergency treatment that was delivered (by a clinician, use...

  42. Chronic wounds: advanced wound dressings and antimicrobial dressings (ESMPB2)

    Summary of the evidence on advanced wound dressings and antimicrobial dressings for managing chronic wounds to inform local NHS planning and decision-making

  43. Thiazide: In people with acute heart failure and persistent congestion, does the addition of a thiazide diuretic to standard therapy lead to greater diuresis compared with adding placebo to standard therapy?

    hospital for treatment of decompensated heart failure. One of the most common and difficult to manage problems arising during the...

  44. Routine outcome measurement:- In people with a common mental health disorder, what is the clinical utility of routine outcome measurement and is it cost effective compared with standard care?

    improved treatment outcomes, because of its impact on healthcare professionals' behaviour and the prompter availability of appropriate...

  45. Lisocabtagene maraleucel for treating relapsed or refractory low-grade B-cell follicular lymphoma after 1 or more treatments [ID6564]

    Awaiting development Reference number: GID-TA11754 Expected publication date: TBC

  46. Adults' uptake of and engagement with interventions for social anxiety disorder:- What methods are effective in improving uptake of and engagement with interventions for adults with social anxiety disorder?

    of people with social anxiety disorder never receive treatment; of those who do receive treatment many wait 10 years or...

  47. Are there subgroups of people with Graves' disease who have a particularly good response to antithyroid drugs?

    that continued follow-up of people who have undergone radioactive iodine treatment was important and the 'as low as reasonably...